Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. | 33,500 | reported | 05 Jun 2025 | tx 6+191,010 |
| Acrivon Therapeutics, Inc. | 9,366 | reported | 18 May 2026 | tx 4+82,416 |
| ARRAY BIOPHARMA INC | 5,000 | reported | 30 Jul 2019 | tx 31+285,000−285,000 |
| Poseida Therapeutics, Inc. | 0 | reported | 08 Jan 2025 | tx 10+190,300−190,300 |
| IMMUNOMEDICS INC | 0 | reported | 23 Oct 2020 | tx 8+59,502−59,502 |
| Mirati Therapeutics, Inc. | 0 | reported | 23 Jan 2024 | tx 136+2,095,087−2,125,607 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 9,366 | 0.00 USD | |
| 13 Jun 2025 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 20,275 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 33,500 | 0.00 USD | deriv |
| 08 Jan 2025 | TENDER | Poseida Therapeutics, Inc. | 78,600 | — | |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 27,350 | 0.00 USD | deriv |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 27,350 | 0.00 USD | deriv |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 57,000 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 20,275 | 0.00 USD | deriv |
| 17 Jun 2024 | GRANT_AWARD | Poseida Therapeutics, Inc. | 19,650 | 0.00 USD | |
| 17 Jun 2024 | GRANT_AWARD | Poseida Therapeutics, Inc. | 27,350 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 67,500 | 0.00 USD | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 123,389 | — | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 94,057 | — | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 20,425 | — | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 100,273 | — | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 69,258 | — | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 81,458 | — | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 111,652 | — | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 178,052 | — | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 7,520 | — | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 168,441 | — | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 1,559 | — | deriv |
| 29 Dec 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 20,425 | 58.75 USD | |
| 09 Aug 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 54,054 | 37.00 USD | |
| 22 Jun 2023 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 32,500 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 14 Jun 2016.